Open-Label, Randomized Study Evaluating Treatment With Venlafaxine Extended-Release Plus Dialogues Time to Talk Program

Completed · Phase 4

Conditions studied: Depressive Disorder, Major

In brief

The purpose of this study is to evaluate the effect of the Dialogues Time to Talk program in subjects treated with Venlafaxine Extended Release (ER). Dialogues Time to Talk Program is a patient management program, which aims to help patients achieve successful outcomes by reinforcing physician treatment efforts, providing feedback to treating physicians, and encouraging better physician-patient communications.

Key facts

Study ID

NCT00401726

Run by

Wyeth is now a wholly owned subsidiary of Pfizer

People needed

537

Starts

2006-06-01

Expected to finish

2007-10-01

Last updated by the study team

2012-04-23

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Currently experiencing a major depressive episode, which requires the initiation of antidepressant drug treatment or a change in current antidepressant drug treatment
• At least 18 years of age

You may not qualify if…

• History or presence of bipolar disorder
• Current treatment with venlafaxine

Where it is running

• Study site — Birmingham, Alabama, United States
• Study site — Birmingham, Alabama, United States
• Study site — Mesa, Arizona, United States
• Study site — Little Rock, Arkansas, United States
• Study site — San Jose, California, United States
• Study site — Avon, Connecticut, United States
• Study site — Cromwell, Connecticut, United States
• Study site — Wilmington, Delaware, United States
• Study site — Ocala, Florida, United States
• Study site — Pinellas Park, Florida, United States
• Study site — Stuart, Florida, United States
• Study site — Atlanta, Georgia, United States
• Study site — Cartersville, Georgia, United States
• Study site — Rome, Georgia, United States
• Study site — Idaho Falls, Idaho, United States
• Study site — Newburgh, Indiana, United States
• Study site — Waterloo, Iowa, United States
• Study site — Metairie, Louisiana, United States
• Study site — Benzonia, Michigan, United States
• Study site — Interlochen, Michigan, United States
• Study site — Kalamazoo, Michigan, United States
• Study site — Chesterfield, Missouri, United States
• Study site — Omaha, Nebraska, United States
• Study site — Las Vegas, Nevada, United States
• Study site — Charlotte, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.